NasdaqGM:ALVOBiotechs
Alvotech (ALVO) Valuation Check As New $100 Million Loan Supports Biosimilar Launch Plans
Alvotech (ALVO) has secured a $100 million senior term loan facility led by GoldenTree Asset Management. The financing is aimed at supporting liquidity and giving the company more flexibility as it advances its biosimilar pipeline and prepares upcoming launches.
See our latest analysis for Alvotech.
The funding deal and upcoming CEO transition arrive after a volatile period, with a 90 day share price return of a 45.10% decline and a 1 year total shareholder return of a 62.96% loss, suggesting...